Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Electronic Emerging pharmaceutical markets Argentina and Mexico Datamonitor, March 2008, Pages: 106   Description     Table of Contents     Companies Mentioned        Enquire before Buying    Send to a Friend   Latin American countries have attracted a lot of attention recently. With their economies currently stable, their geographic location and low-cost is ideal for investors. In addition, having such a high and varied population eases recruitment for clinical trials, and the demographics show there is a very high need for pharmaceuticals. Scope - Overview of the key trends driving the pharmaceutical market growth - Analysis of key healthcare system characteristics impacting the pharmaceutical market - Analysis of pharmaceutical market dynamics in Argentina and Mexico - Overview of key pharmaceutical players in Argentina and Mexico Highlights of this title Although both the Argentinean and the Mexican markets have been growing, their growth is attributed to different reasons. The Argentinean pharmaceutical market has been growing mainly based on growing sales volume, while growth of the Mexican market is mainly driven by growing prices. The Mexican market is dominated by foreign companies with few domestic players. The Argentinean market is dominated by domestic branded generics firms, due to the economic crisis which led to many foreign companies to sell their plants in Argentina, thus allowing the domestic firms to gain over their market share. Sales of pharmaceutical categories in both countries are very similar to the West thus opening growth opportunities for foreign companies. However, sales of oncology drugs are low in both countries; and Mexico has higher sales of anti-infective drugs indicating that these markets still have scope for further development and growth. Key reasons to purchase this title - Identify the healthcare needs in Argentina and Mexico - Understand the barriers and drivers for entering these markets - Gain insight into pharmaceutical dynamics of Argentina and Mexico Customers who bought this item also bought Brazilian and Mexican DCS and PLC Markets MVNOs in Emerging Markets: Developing the Business Case for the MVNO Model Strategies to Accelerate Handset Financing in Emerging Markets The Citigroup European Emerging Markets Directory 2007 Emerging Markets Series: Benchmarking Key Countries Brazil, Russia, India, China and Turkey The Pharmaceutical Market: Mexico Chinese Markets for Industrial Coatings Emerging Pharmaceutical Markets: Growth Opportunities, Changing Healthcare Dynamics and Regulatory Trends

		Top of page

All rights reserved. Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster